Enhertu

Client: AstraZeneca/Daiichi-Sankyo
Agency: Ogilvy Health
Role: Senior Art Director

Challenge:
The launch of Enhertu, a cutting-edge treatment for HER2-positive breast cancer, required a comprehensive suite of marketing and educational materials to engage both healthcare professionals (HCPs) and patients. The challenge was to effectively communicate the drug’s benefits, mechanism of action, and clinical impact while maintaining clarity, empathy, and scientific accuracy.

Solution:
As part of the launch team at Ogilvy Health, I played a key role in developing a range of materials that supported both HCP education and patient awareness, ensuring a seamless introduction of Enhertu to the market. My contributions included:

• Journal ads to drive awareness among oncologists and HCPs.

• Brochures providing in-depth information on treatment benefits, patient eligibility, and support resources.

• Emails targeted at both HCPs and patients, delivering key messaging in a concise and engaging format.

• Infographics that simplified complex clinical data, making information more accessible for both medical professionals and patients.